Cloudmd Software Services Stock Current Valuation
Valuation analysis of CloudMD Software Services helps investors to measure CloudMD Software's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
CloudMD Software Services Company Current Valuation Analysis
CloudMD Software's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CloudMD Software Current Valuation | 45.4 M |
Most of CloudMD Software's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CloudMD Software Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, CloudMD Software Services has a Current Valuation of 45.4 M. This is 99.68% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The current valuation for all United States stocks is 99.73% higher than that of the company.
CloudMD Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CloudMD Software's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CloudMD Software could also be used in its relative valuation, which is a method of valuing CloudMD Software by comparing valuation metrics of similar companies.CloudMD Software is currently under evaluation in current valuation category among its peers.
CloudMD Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 | |||
| Profit Margin | (1.06) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 45.4 M | |||
| Shares Outstanding | 293.29 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 0.72 % | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 102.33 M | |||
| Gross Profit | 5.76 M | |||
| EBITDA | (20.91 M) | |||
| Net Income | (30.73 M) | |||
| Cash And Equivalents | 29.7 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 22.13 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 1.67 X | |||
| Book Value Per Share | 0.43 X | |||
| Cash Flow From Operations | (21.86 M) | |||
| Earnings Per Share | (0.10) X | |||
| Number Of Employees | 11 | |||
| Beta | 1.59 | |||
| Market Capitalization | 45.15 M | |||
| Total Asset | 327.36 M | |||
| Z Score | 1.2 | |||
| Net Asset | 327.36 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in CloudMD Pink Sheet
If you are still planning to invest in CloudMD Software Services check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CloudMD Software's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |